These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 8772721)

  • 21. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
    Bonifacio E; Lampasona V; Bingley PJ
    J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-lymphocyte changes linked to autoantibodies. Association of insulin autoantibodies with CD4+CD45R+ lymphocyte subpopulation in prediabetic subjects.
    Faustman D; Schoenfeld D; Ziegler R
    Diabetes; 1991 May; 40(5):590-7. PubMed ID: 1827080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.
    Hatziagelaki E; Jaeger C; Petzoldt R; Seissler J; Scherbaum WA; Federlin K; Bretzel RG
    Horm Metab Res; 1999 Oct; 31(10):564-9. PubMed ID: 10596966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes.
    Naserke HE; Ziegler AG; Lampasona V; Bonifacio E
    J Immunol; 1998 Dec; 161(12):6963-9. PubMed ID: 9862731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.
    Jaeger C; Hatziagelaki E; Stroedter A; Becker F; Scherer S; Petzoldt R; Federlin K; Bretzel RG
    Exp Clin Endocrinol Diabetes; 1999; 107(8):496-505. PubMed ID: 10612480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of the importance of antibodies against islet cells (ICA) and Glutamate Decarboxylase(anti-GAD) for determining prognosis of diabetes type 1 in the Polish population--5 year observation].
    Kretowski A; Szelachowska M; Kinalska I
    Pol Arch Med Wewn; 1999 Apr; 101(4):323-7. PubMed ID: 10740410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple antibody status in type 1 diabetic patients and subjects at various risk with islet-cell antibodies.
    Maugendre D; Chaillous L; Rohmer V; Lecomte P; Marechaud R; Saï P; Marre M; Charbonnel B; Allannic H; Delamaire M
    Diabetes Metab; 1997 Sep; 23(4):320-6. PubMed ID: 9342546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triple chimeric islet autoantigen IA2-ZnT8WR to facilitate islet autoantibody determination.
    Yu L; Liu Y; Miao D; Wenzlau J; Davidson H; Hutton J; Eisenbarth GS
    J Immunol Methods; 2010 Feb; 353(1-2):20-3. PubMed ID: 20035758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-ganglioside autoantibodies in type 1 diabetes.
    Lucchetta M; Rudilosso S; Costa S; Bruttomesso D; Ruggero S; Toffanin E; Faggian D; Plebani M; Battistin L; Alaedini A; Briani C
    Muscle Nerve; 2010 Jan; 41(1):50-3. PubMed ID: 19768773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel considerations on the antibody/autoantigen system in type I (insulin-dependent) diabetes mellitus.
    Bottazzo GF; Genovese S; Bosi E; Dean BM; Christie MR; Bonifacio E
    Ann Med; 1991 Oct; 23(4):453-61. PubMed ID: 1930942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age- and islet autoimmunity-associated differences in amino acid and lipid metabolites in children at risk for type 1 diabetes.
    Pflueger M; Seppänen-Laakso T; Suortti T; Hyötyläinen T; Achenbach P; Bonifacio E; Orešič M; Ziegler AG
    Diabetes; 2011 Nov; 60(11):2740-7. PubMed ID: 22025777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 64,000 Mr autoantibodies as predictors of insulin-dependent diabetes.
    Atkinson MA; Maclaren NK; Scharp DW; Lacy PE; Riley WJ
    Lancet; 1990 Jun; 335(8702):1357-60. PubMed ID: 1971659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The high prevalence of autoantibodies to tissue transglutaminase in first-degree relatives of patients with type 1 diabetes is not associated with islet autoimmunity.
    Williams AJ; Norcross AJ; Lock RJ; Unsworth DJ; Gale EA; Bingley PJ
    Diabetes Care; 2001 Mar; 24(3):504-9. PubMed ID: 11289476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Life-table analysis of progression to diabetes of anti-insulin autoantibody-positive relatives of individuals with type I diabetes.
    Ziegler AG; Ziegler R; Vardi P; Jackson RA; Soeldner JS; Eisenbarth GS
    Diabetes; 1989 Oct; 38(10):1320-5. PubMed ID: 2676660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perinatal autoimmunity in offspring of diabetic parents. The German Multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood.
    Roll U; Christie MR; Füchtenbusch M; Payton MA; Hawkes CJ; Ziegler AG
    Diabetes; 1996 Jul; 45(7):967-73. PubMed ID: 8666150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoreactivity to a 64,000 Mr human islet cell antigen in sera from insulin-dependent diabetes mellitus patients and individuals with abnormal glucose tolerance.
    Baekkeskov S
    Mol Biol Med; 1986 Apr; 3(2):137-42. PubMed ID: 3526081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes.
    Gianani R; Pugliese A; Bonner-Weir S; Shiffrin AJ; Soeldner JS; Erlich H; Awdeh Z; Alper CA; Jackson RA; Eisenbarth GS
    Diabetes; 1992 Mar; 41(3):347-53. PubMed ID: 1551494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial.
    Füchtenbusch M; Rabl W; Grassl B; Bachmann W; Standl E; Ziegler AG
    Diabetologia; 1998 May; 41(5):536-41. PubMed ID: 9628270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of ICA512 antibodies for prediction and diagnosis of type 1 diabetes.
    Mayrhofer M; Rabin DU; Messenger L; Standl E; Ziegler AG
    Exp Clin Endocrinol Diabetes; 1996; 104(3):228-34. PubMed ID: 8817240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating antibodies against an exocrine pancreatic enzyme in type 1 diabetes.
    Panicot L; Mas E; Thivolet C; Lombardo D
    Diabetes; 1999 Dec; 48(12):2316-23. PubMed ID: 10580419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.